Quest Diagnostics unveiled a new artificial intelligence-based test service in the U.S. that aims to help physicians improve the detection of dementia and create better outcomes for patients. Through ...

In September 2024, Quest Diagnostics was awarded several contracts by the U.S. Centers for Disease Control and Prevention (CDC) to support testing and sustained laboratory readiness for emerging ...

Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...

Quest Diagnostics Incorporated DGX recently announced that the company is now offering the liquid biopsy-based Target Selector NGS Lung Panel test developed by Biocept BIOC. The addition of this blood ...

With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the customer experience for health systems, hospitals, independent providers and ...

Quest Diagnostics now offers two consumer-initiated and physician-ordered COVID-19 diagnostic test options for active COVID-19 infection, according to a release. The testing kit can be purchased ...

Quest Diagnostics and Quest Diagnostics Foundation are launching a $100 million investment program to reduce disparities in communities hardest hit by the coronavirus pandemic. Officials said the ...